FDA Investigator Jenny L Chisem
Jenny L Chisem has conducted inspections on 33 sites in 4 countries as of 22 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
33
Last Inspection Date:
22 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Dominican Republic,
United Kingdom of Great Britain and Northern Ireland,
Mexico
FDA Investigators that have inspected at least one site in common with Jenny L Chisem:
Ademola O Daramola,
Allen F Hall,
Anderson,
Angela Shepas,
Cathleen A Carr Sharpe,
Charles L Larson,
Christian D Lynch (CDL),
Christine I Shaw,
Dannie E Rowland,
David P Vanhouten,
Dr. Guang Gao, PhD,
Durell L Giles,
Elizabeth A Dakan,
Finn A Slizza,
Gamal A Norton,
Gene D Arcy,
James A Lane,
James R Montero,
Jenny L Mccardell,
Juanita Banuelos,
Juanj N Wu,
Kari M Johansen,
Kelley,
Kelvin Cheung,
LCDR Wilfred A Darang,
Leonard H Lavi,
Linda Galindo,
Linda Thai,
Lori J Silverstein,
Marcia G Evans,
Mariza M Jafary,
Michael D Garcia,
Naveen B Walker,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Sara Jdent Acosta,
Sara M Onyango,
Sara M Richardson,
Sarah A Hassas,
Scott K Zika,
Shaquenta Y Perkins,
Sharon I Gundersen,
Stephen R Souza,
Tamala P Bogan,
Tamala P Magee,
Trudy R Papson,
Uros V Djekic, PhD,
Vickie L Anderson,
Vicky L Cruz,
Virgilio F Pacio, CSO,
William S Vitale,
Yvette E Elacio,
Yvette E Guillermo
Jenny L Chisem's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2024 | FDA 483 | ARTVENTIVE MEDICAL GROUP, INC. - Form 483, 2024-02-01 |
April, 2024 | FDA 483 | Avacen Inc. - Form 483, 2024-04-12 |
March, 2024 | FDA 483 | Sacks Holdings, Inc. - Form 483, 2024-03-29 |
December, 2023 | FDA 483 | Anesthesia Associates Inc - Form 483, 2023-12-18 |
October, 2022 | FDA 483 | Hologic, Inc. - Form 483, 2022-10-14 |
September, 2023 | FDA 483 | Medwaves Inc - Form 483, 2023-09-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more